Bradley Saenger insider trades

Open-market stock purchases and sales by Bradley Saenger, Chief Financial Officer at Tonix Pharmaceuticals Holding Corp, from SEC Form 4 filings since May 27, 2016.

Track record: 100% of 2 scored buys are up 5% or more since purchase, averaging +91%.

Recent trades

DateStockTradeValue
Jun 30, 2026TNXP Tonix Pharmaceuticals Holding CorpBought (not open market)$15.9K
Feb 24, 2026TNXP Tonix Pharmaceuticals Holding CorpBought (not open market)—
Feb 24, 2026TNXP Tonix Pharmaceuticals Holding CorpBought (not open market)—

Companies traded

  • TNXP Tonix Pharmaceuticals Holding Corp: 2 buys, last Jun 30, 2026

Get free alerts when Bradley Saenger files a new trade →